Genomic Laboratory Hub Services
In order to support the interpretation of genomic data and its integration within the clinical Multi-Disciplinary Team process a series of genomic advisory boards have been established.
Genomic Rare Disease Advisory Boards (GRDABs) and Genomic Tumour Advisory Boards (GTABs).
These are multi-disciplinary teams who analyse the more complex genomic results which arise from testing for larger numbers of gene abnormalities.
The Boards will act in an advisory capacity, reviewing and providing interpretation of complex genetic testing including large gene panels, specialised services and whole genome sequencing. Output from the GTAB/GRDAB will be fed into the clinical MDT for a final decision in conjunction with clinical information.
Genome Sequencing Review Process
The NE&Y GLH has established genomic advisory boards in the following areas:
Clinical Lead Dr Jackie Cook, Sheffield Children’s Hospital NHS Foundation Trust
Including review of Specialised Services
Inherited Cancer GRDAB
Solid Tumour GTAB
Pathology Clinical Lead Dr Sally Lane, Leeds Teaching Hospital Trust
Oncology Clinical Lead Dr Alastair Greystoke, Newcastle upon Tyne Hospitals NHS Foundation Trust
Paediatric Oncology GTAB
Clinical Lead Dr Simon Bomken, Newcastle upon Tyne Hospitals NHS Foundation Trust
Clinical Leads Dr Catherine Cargo, Leeds teaching Hospital NHS Trust
& Dr Chris Bacon, Newcastle Hospitals NHS Foundation Trust